List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 425 studies with search of: Open Studies | "Myelodysplastic Syndromes"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Sodium Stibogluconate in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: sodium stibogluconate
2 Not yet recruiting Studying Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Hematopoietic/Lymphoid Cancer;   Accelerated Phase Chronic Myelogenous Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Childhood Chronic Myelogenous Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Recurrent Adult Acute Lymphoblastic Leukemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Adult Acute Myeloid Leukemia in Remission;   Recurrent Adult Acute Myeloid Leukemia;   Childhood Acute Myeloid Leukemia in Remission;   Recurrent Childhood Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic/Myeloproliferative Disease, Unclassifiable;   Childhood Myelodysplastic Syndromes;   de Novo Myelodysplastic Syndromes;   Secondary Myelodysplastic Syndromes;   HIV-associated Hodgkin Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Burkitt Lymphoma;   HIV Infections
Interventions: Procedure: leukapheresis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Other: laboratory biomarker analysis;   Other: DNA analysis;   Other: RNA analysis;   Other: flow cytometry;   Other: reverse transcriptase-polymerase chain reaction;   Other: nucleic acid sequencing;   Other: protein expression analysis
3 Recruiting Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Conditions: Advanced Myelodysplastic Syndrome;   Myelodysplastic Syndrome;   Secondary Acute Myeloid Leukemia After MDS;   Thrombocytopenia
Interventions: Drug: eltrombopag olamine;   Other: Placebo
4 Recruiting Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: decitabine;   Drug: tretinoin;   Genetic: DNA methylation analysis;   Genetic: cytogenetic analysis;   Genetic: microarray analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunohistochemistry staining method
5 Recruiting Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: thioguanine
6 Not yet recruiting Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: lintuzumab;   Drug: azacitidine;   Other: pharmacological study
7 Recruiting Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Biological: GM-K562 cell vaccine;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
8 Not yet recruiting Everolimus in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: everolimus;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis
9 Recruiting PXD101 in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: belinostat
10 Recruiting Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: sorafenib tosylate
11 Recruiting Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: alemtuzumab;   Drug: arsenic trioxide;   Drug: azacitidine;   Drug: busulfan;   Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: melphalan;   Drug: tipifarnib;   Genetic: DNA methylation analysis;   Genetic: cytogenetic analysis;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
12 Not yet recruiting Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Condition: Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Drug: Deferasirox placebo
13 Recruiting Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: azacitidine;   Drug: lenalidomide
14 Recruiting Iodine I 131 Monoclonal Antibody BC8, Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Procedure: peripheral blood stem cell transplantation;   Radiation: iodine I 131 monoclonal antibody BC8;   Radiation: radiation therapy
15 Recruiting Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   MDS
Intervention: Drug: Gimatecan
16 Recruiting A Dose Confirmation Study of Oral Clofarabine for Previously Treated Adult Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS)
Condition: Myelodysplastic Syndromes
Intervention: Drug: clofarabine
17 Recruiting Alemtuzumab and Cyclosporine in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Biological: alemtuzumab;   Drug: cyclosporine
18 Recruiting DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: DT(388)IL3 fusion protein;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
19 Recruiting Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: Lenalidomide, Decitabine
20 Recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: azacitidine;   Drug: vorinostat

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services